class action lawsuit

Class action filed against Lakeland Industries alleging executives misrepresented Pacific Helmets and Jolly performance while hiding operational issues including shipping delays and tariff pressures.

Bath & Body Works faces class action lawsuit alleging executives made false statements about growth strategy effectiveness. Lead plaintiff deadline is March 13, 2026.

Lawsuit filed against $FBRT alleging false statements about dividend sustainability. Investors have until April 27, 2026 to join the case.

Class action lawsuit filed against $PLUG alleging false statements about DOE loan availability and hydrogen facility construction capability.

Class action lawsuit filed against AMC over alleged securities violations regarding APE preferred equity units and distribution rights.

Class action lawsuit filed against BellRing Brands alleging materially false statements about sales driven by inventory accumulation rather than genuine demand.

Aardvark Therapeutics stock plummeted 56.2% after halting Phase 3 trial due to cardiac observations. Law firm investigates potential securities fraud.

FSK stock crashed 19% on dividend cut to $0.48/share and disclosure of $440M non-accrual portfolio assets, prompting securities fraud investigation.

Apollo Global Management faces securities fraud lawsuit over alleged undisclosed Epstein communications involving executives Rowan and Black. Stock fell 16% during disputed period.

Navan faces class action lawsuit alleging material IPO disclosure gaps regarding $95M sales-marketing expenses. April 24, 2026 deadline for lead plaintiff applications.

Class action lawsuit filed against Soleno Therapeutics for allegedly failing to disclose material safety concerns about its DCCR product. Investors can apply as lead plaintiff by May 5, 2026.

Camping World Holdings faces class action lawsuit over alleged false statements about inventory management. Stock fell 25% after Q3 earnings, then 16% after Q4 results; dividend suspended.

Rosen Law Firm files securities class action against $AQST over alleged misleading statements regarding its Anaphylm drug application between June 2025 and January 2026.

Law firm Bragar Eagel & Squire files class action lawsuits against $NAVAN and $COPT alleging material misstatements, citing 60%+ and 50%+ stock declines respectively.

Class action lawsuits filed against $SMR developer NuScale and $OSTN over securities fraud, including $110M scheme and misrepresented nuclear partnerships.

monday.com faces class action lawsuit alleging false growth projections during 2025-2026 period. Stock fell 21% after company abandoned $1.8B 2027 revenue target.

Law firm investigates $BSC for allegedly misleading investors about U.S. Electrophysiology growth sustainability and competitive pressures during July 2025-February 2026 period.

Law firm Bernstein Liebhard announces class action against $NKTR over alleged misrepresentations regarding Phase 2b trial results, affecting investors from February to December 2025.

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability and concealed adverse facts.

Pomerantz LLP investigates Gossamer Bio after seralutinib Phase 3 trial failure triggers 80% stock crash, raising securities fraud concerns.